JB Chemicals & Pharmaceuticals’ API manufacturing facility at Panoli, Gujarat has successfully passed periodical inspection by the US Food and Drug Administration (USFDA) with two minor procedural observations. These observations do not impact continuity of company’s business and the company would continue its manufacturing activities in cGMP compliant manner.
The company proposes to address these observations in next 30 days. The said inspection was carried out from May 07, 2018 to May 11, 2018.
This USFDA/EU/Japan approved API facility primarily manufactures APIs for exports to EU and formulations exports to US.
JB Chemicals & Pharmaceuticals is engaged in manufacturing of pharmaceutical specialties in various dosage forms, herbal remedies, diagnostics, generic drugs, active pharmaceutical ingredients (APIs).
